Through modulating PI3K-AKT-mTOR signaling, Linc01014 overexpression could also dramatically suppress the apoptosis of esophagus cancer cells and promote gefitinib resistance (Fu et al., 2020). This evidence concerns the gene MTOR and esophageal cancer.